Celerion (H.I.G. Capital) website screenshot

Celerion (H.I.G. Capital)

Celerion is a global contract research organization (CRO) specializing in early-stage clinical research, Phase I clinical trials, clinical pharmacology, and bioanalytical services that accelerate drug development from first-in-human studies through proof-of-concept. Headquartered in Lincoln, Nebraska with clinical and bioanalytical sites across North America and Europe, Celerion supports pharmaceutical and biotechnology sponsors with healthy-volunteer and special-population studies, bioanalysis, biomarker assays, ECG/cardiac safety, and its LabNotes bioanalytical data-management software. The company is a portfolio holding of H.I.G. Capital and was surfaced to the API Evangelist network via the bain-capital-ventures portfolio graph. As a corporate/marketing web presence with no public developer or API program, this profile carries only the artifacts that could be observed on the public web (llms.txt, domain-security posture).

Celerion (H.I.G. Capital) is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Clinical Research, Contract Research Organization, and Drug Development.

Celerion (H.I.G. Capital)’s developer surface includes engineering blog and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub
11.2/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyHealthcareClinical ResearchContract Research OrganizationDrug DevelopmentBioanalytical ServicesClinical PharmacologyLife Sciences

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 11.2/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 2.1 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/celerion-hig-capital: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Celerion Hig Capital Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy
PrivacyPolicy

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: celerion-hig-capital
name: Celerion (H.I.G. Capital)
description: Celerion is a global contract research organization (CRO) specializing in early-stage clinical research, Phase
  I clinical trials, clinical pharmacology, and bioanalytical services that accelerate drug development from first-in-human
  studies through proof-of-concept. Headquartered in Lincoln, Nebraska with clinical and bioanalytical sites across North
  America and Europe, Celerion supports pharmaceutical and biotechnology sponsors with healthy-volunteer and special-population
  studies, bioanalysis, biomarker assays, ECG/cardiac safety, and its LabNotes bioanalytical data-management software. The
  company is a portfolio holding of H.I.G. Capital and was surfaced to the API Evangelist network via the bain-capital-ventures
  portfolio graph. As a corporate/marketing web presence with no public developer or API program, this profile carries only
  the artifacts that could be observed on the public web (llms.txt, domain-security posture).
url: https://raw.githubusercontent.com/api-evangelist/celerion-hig-capital/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- bain-capital-ventures
x-tier: stub
x-tier-reason: portfolio-lead
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://www.celerion.com/wp-content/uploads/2026/01/LOGO-Dark@2x-withfulltagline.png
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Healthcare
- Clinical Research
- Contract Research Organization
- Drug Development
- Bioanalytical Services
- Clinical Pharmacology
- Life Sciences
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.celerion.com/
- type: Blog
  url: https://www.celerion.com/blog/
- type: PrivacyPolicy
  url: https://www.celerion.com/privacy-policy/
- type: LLMsTxt
  url: llms/celerion-hig-capital-llms.txt
- type: DomainSecurity
  url: security/celerion-hig-capital-domain-security.yml
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence